Publication:
The role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations

dc.contributor.authorOgut, E.
dc.contributor.authorArmagan, Kutay
dc.contributor.authorGül, Zülfiye
dc.contributor.institutionOgut, E., Department of Anatomy, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.contributor.institutionArmagan, Kutay, Medical Faculty Student, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.contributor.institutionGül, Zülfiye, Department of Pharmacology, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.date.accessioned2025-10-05T15:19:16Z
dc.date.issued2022
dc.description.abstractHundreds of millions of people are influenced by neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), traumatic disorders of the nervous system, dementia, and various neurological disorders. Syringic acid (SA) is a natural phenolic compound that is found in medicinal herbs and dietary plants. The therapeutic potential of SA is due to its anti-oxidative, chemoprotective, anti-angiogenic, anti-glycating, anti-proliferative, anti-hyperglycaemic, anti-endotoxic, anti-microbial, anti-inflammatory, anti-diabetic and anti-depressant properties. However, in recent studies, its neuroprotective effect has drawn attention. The current review focuses on the neuroprotective bioactivities of SA and putative mechanisms of action. An electronic data search was performed using different search engines, and the relevant articles (with or without meta-analysis) with any language were selected. In the central and peripheral nervous system, SA has been shown a significant role in excitatory neurotransmitters and alleviate behavioral dysfunctions. The consensus of the literature search was that SA treatment may help neurological dysfunction or behavioral impairments management with antioxidant, anti-inflammatory properties. Furthermore, administration and proper dose of SA could be crucial factors for the effective treatment of neurological diseases. © 2022 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1007/s11011-022-00960-3
dc.identifier.endpage880
dc.identifier.issn15737365
dc.identifier.issn08857490
dc.identifier.issue4
dc.identifier.pubmed35334041
dc.identifier.scopus2-s2.0-85127288053
dc.identifier.startpage859
dc.identifier.urihttps://doi.org/10.1007/s11011-022-00960-3
dc.identifier.urihttps://hdl.handle.net/20.500.14719/8839
dc.identifier.volume37
dc.language.isoen
dc.publisherSpringer
dc.relation.sourceMetabolic Brain Disease
dc.subject.authorkeywordsBrain
dc.subject.authorkeywordsNeurodegenerative Disorders
dc.subject.authorkeywordsNeurological Diseases
dc.subject.authorkeywordsNeuroprotective
dc.subject.authorkeywordsSyringic Acid
dc.subject.authorkeywordsSyringic Acid
dc.subject.authorkeywordsGallic Acid
dc.subject.authorkeywordsAnti-inflammatory Agents
dc.subject.authorkeywordsGallic Acid
dc.subject.authorkeywordsNeuroprotective Agents
dc.subject.authorkeywordsSyringic Acid
dc.subject.authorkeywordsNeurotransmitter
dc.subject.authorkeywordsSyringic Acid
dc.subject.authorkeywordsAntiinflammatory Agent
dc.subject.authorkeywordsGallic Acid
dc.subject.authorkeywordsNeuroprotective Agent
dc.subject.authorkeywordsAntiinflammatory Activity
dc.subject.authorkeywordsAntioxidant Activity
dc.subject.authorkeywordsBehavior Disorder
dc.subject.authorkeywordsCentral Nervous System
dc.subject.authorkeywordsDegenerative Disease
dc.subject.authorkeywordsDrug Mechanism
dc.subject.authorkeywordsHuman
dc.subject.authorkeywordsNeuroprotection
dc.subject.authorkeywordsNonhuman
dc.subject.authorkeywordsPeripheral Nervous System
dc.subject.authorkeywordsReview
dc.subject.authorkeywordsMotivation
dc.subject.authorkeywordsAnti-inflammatory Agents
dc.subject.authorkeywordsGallic Acid
dc.subject.authorkeywordsHumans
dc.subject.authorkeywordsMotivation
dc.subject.authorkeywordsNeurodegenerative Diseases
dc.subject.authorkeywordsNeuroprotective Agents
dc.subject.indexkeywordsneurotransmitter
dc.subject.indexkeywordssyringic acid
dc.subject.indexkeywordsantiinflammatory agent
dc.subject.indexkeywordsgallic acid
dc.subject.indexkeywordsneuroprotective agent
dc.subject.indexkeywordsantiinflammatory activity
dc.subject.indexkeywordsantioxidant activity
dc.subject.indexkeywordsbehavior disorder
dc.subject.indexkeywordscentral nervous system
dc.subject.indexkeywordsdegenerative disease
dc.subject.indexkeywordsdrug mechanism
dc.subject.indexkeywordshuman
dc.subject.indexkeywordsneuroprotection
dc.subject.indexkeywordsnonhuman
dc.subject.indexkeywordsperipheral nervous system
dc.subject.indexkeywordsReview
dc.subject.indexkeywordsmotivation
dc.subject.indexkeywordsAnti-Inflammatory Agents
dc.subject.indexkeywordsGallic Acid
dc.subject.indexkeywordsHumans
dc.subject.indexkeywordsMotivation
dc.subject.indexkeywordsNeurodegenerative Diseases
dc.subject.indexkeywordsNeuroprotective Agents
dc.titleThe role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations
dc.typeReview
dcterms.referencesAbaza, Mohamed Salah I., Syringic acid from Tamarix aucheriana possesses antimitogenic and chemo-sensitizing activities in human colorectal cancer cells, Pharmaceutical Biology, 51, 9, pp. 1110-1124, (2013), Arumugam, Balasubramanian, Syringic acid, a phenolic acid, promotes osteoblast differentiation by stimulation of Runx2 expression and targeting of Smad7 by miR-21 in mouse mesenchymal stem cells, Journal of Cell Communication and Signaling, 12, 3, pp. 561-573, (2018), Baǧdaş, Deniz, Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation, Current Neuropharmacology, 18, 3, pp. 216-228, (2020), Belkheiri, Nadji, Synthesis and antioxidant activity evaluation of a syringic hydrazones family, European Journal of Medicinal Chemistry, 45, 7, pp. 3019-3026, (2010), Cao, Yidong, Neuroprotective effects of syringic acid against OGD/R-induced injury in cultured hippocampal neuronal cells, International Journal of Molecular Medicine, 38, 2, pp. 567-573, (2016), Chen, Suio, Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches, Neurobiology of Aging, 17, 5, pp. 781-787, (1996), Cho, Jeongyong Young, Antimicrobial activity of 4-hydroxybenzoic acid and trans 4-hydroxycinnamic acid isolated and identified from rice hull, Bioscience, Biotechnology and Biochemistry, 62, 11, pp. 2273-2276, (1998), Çikman, Öztekin, Antioxidant activity of syringic acid prevents oxidative stress in l-arginine-induced acute pancreatitis: An experimental study on rats, International Surgery, 100, 5, pp. 891-896, (2015), Clark, Richard Af F., Cutaneous tissue repair: Basic biologic considerations. I, Journal of the American Academy of Dermatology, 13, 5, pp. 701-725, (1985), Costa, Mírian Feliciano, Eugenia aurata and Eugenia punicifolia HBK inhibit inflammatory response by reducing neutrophil adhesion, degranulation and NET release, BMC Complementary and Alternative Medicine, 16, 1, (2016)
dspace.entity.typePublication
local.indexed.atScopus
person.identifier.scopus-author-id56403159500
person.identifier.scopus-author-id57221281229
person.identifier.scopus-author-id56086542900

Files